Vernooij R, Michael M, Colombijn J, Owers D, Webster A, Strippoli G
Cochrane Database Syst Rev. 2025; 1():CD005133.
PMID: 39807668
PMC: 11729901.
DOI: 10.1002/14651858.CD005133.pub4.
Wajih Z, Karpe K, Walters G
Cochrane Database Syst Rev. 2024; 10:CD013344.
PMID: 39382091
PMC: 11462636.
DOI: 10.1002/14651858.CD013344.pub2.
Dhital R, Anand S, Graber B, Zeng Q, Velazquez V, Boddeda S
Am J Transplant. 2022; 22(10):2306-2322.
PMID: 35671112
PMC: 9547825.
DOI: 10.1111/ajt.17116.
Rodriguez-Goncer I, Ruiz-Ruigomez M, Lopez-Medrano F, Trujillo H, Gonzalez E, Polanco N
Transpl Int. 2022; 35:10273.
PMID: 35185374
PMC: 8842254.
DOI: 10.3389/ti.2021.10273.
Higdon L, Schaffert S, Cohen R, Montez-Rath M, Lucia M, Saligrama N
J Immunol. 2021; 207(8):2086-2095.
PMID: 34551963
PMC: 8492533.
DOI: 10.4049/jimmunol.2100405.
Association of Premature Immune Aging and Cytomegalovirus After Solid Organ Transplant.
Higdon L, Gustafson C, Ji X, Sahoo M, Pinsky B, Margulies K
Front Immunol. 2021; 12:661551.
PMID: 34122420
PMC: 8190404.
DOI: 10.3389/fimmu.2021.661551.
CRISPR-Cas9-Edited Tacrolimus-Resistant Antiviral T Cells for Advanced Adoptive Immunotherapy in Transplant Recipients.
Amini L, Wagner D, Rossler U, Zarrinrad G, Wagner L, Vollmer T
Mol Ther. 2020; 29(1):32-46.
PMID: 32956624
PMC: 7791012.
DOI: 10.1016/j.ymthe.2020.09.011.
Comprehensive Characterization of a Next-Generation Antiviral T-Cell Product and Feasibility for Application in Immunosuppressed Transplant Patients.
Amini L, Vollmer T, Wendering D, Jurisch A, Landwehr-Kenzel S, Otto N
Front Immunol. 2019; 10:1148.
PMID: 31191530
PMC: 6546853.
DOI: 10.3389/fimmu.2019.01148.
Risk factors for complications and graft failure in kidney transplant patients with sepsis.
Syu S, Lin Y, Lin K, Lee L, Hsiao C, Wen Y
Bosn J Basic Med Sci. 2018; 19(3):304-311.
PMID: 30242808
PMC: 6716102.
DOI: 10.17305/bjbms.2018.3874.
Sequence homology between HLA-bound cytomegalovirus and human peptides: A potential trigger for alloreactivity.
Hall C, Koparde V, Jameson-Lee M, Elnasseh A, Scalora A, Kobulnicky D
PLoS One. 2017; 12(8):e0178763.
PMID: 28800601
PMC: 5553991.
DOI: 10.1371/journal.pone.0178763.
Dual Role of Natural Killer Cells on Graft Rejection and Control of Cytomegalovirus Infection in Renal Transplantation.
Lopez-Botet M, Vilches C, Redondo-Pachon D, Muntasell A, Pupuleku A, Yelamos J
Front Immunol. 2017; 8:166.
PMID: 28261220
PMC: 5311043.
DOI: 10.3389/fimmu.2017.00166.
Kidney Fibrosis: Origins and Interventions.
Vanhove T, Goldschmeding R, Kuypers D
Transplantation. 2016; 101(4):713-726.
PMID: 27941433
PMC: 7228593.
DOI: 10.1097/TP.0000000000001608.
Adoptive T cell therapy for the treatment of viral infections.
Arasaratnam R, Leen A
Ann Transl Med. 2015; 3(18):278.
PMID: 26605324
PMC: 4630547.
DOI: 10.3978/j.issn.2305-5839.2015.10.12.
Direct and Indirect Effects of Cytomegalovirus-Induced γδ T Cells after Kidney Transplantation.
Couzi L, Pitard V, Moreau J, Merville P, Dechanet-Merville J
Front Immunol. 2015; 6:3.
PMID: 25653652
PMC: 4301015.
DOI: 10.3389/fimmu.2015.00003.
Prevalence and risk factors for early chronic allograft nephropathy in a live related renal transplant program.
Khan H, Mubarak M, Aziz T, Ahmed E, Fazal Akhter S, Kazi J
J Nephropathol. 2014; 3(2):69-79.
PMID: 24772400
PMC: 3999587.
DOI: 10.12860/jnp.2014.15.
Cytomegalovirus-responsive γδ T cells: novel effector cells in antibody-mediated kidney allograft microcirculation lesions.
Bachelet T, Couzi L, Pitard V, Sicard X, Rigothier C, Lepreux S
J Am Soc Nephrol. 2014; 25(11):2471-82.
PMID: 24744438
PMC: 4214528.
DOI: 10.1681/ASN.2013101052.
Causal inference regarding infectious aetiology of chronic conditions: a systematic review.
Orrskog S, Medin E, Tsolova S, Semenza J
PLoS One. 2013; 8(7):e68861.
PMID: 23935899
PMC: 3723854.
DOI: 10.1371/journal.pone.0068861.
Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients.
Owers D, Webster A, Strippoli G, Kable K, Hodson E
Cochrane Database Syst Rev. 2013; 2):CD005133.
PMID: 23450558
PMC: 6823220.
DOI: 10.1002/14651858.CD005133.pub3.
Viral infection in renal transplant recipients.
Cukuranovic J, Ugrenovic S, Jovanovic I, Visnjic M, Stefanovic V
ScientificWorldJournal. 2012; 2012:820621.
PMID: 22654630
PMC: 3357934.
DOI: 10.1100/2012/820621.
Ganciclovir transiently attenuates murine cytomegalovirus-associated renal allograft inflammation.
Shimamura M, Saunders U, Rha B, Guo L, Cassady K, George J
Transplantation. 2011; 92(7):759-66.
PMID: 21878840
PMC: 6064209.
DOI: 10.1097/TP.0b013e31822c6e89.